Article
Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier.
Journal of controlled release : official journal of the Controlled Release Society - 10 Nov 2015
Yokoi Kenji, Chan Diana, Kojic Milos, Milosevic Miljan, Engler David, Matsunami Rise, Tanei Tomonori, Saito Yuki, Ferrari Mauro, Ziemys Arturas
Abstract excerpt
Although nanotherapeutics can be advantageous over free chemotherapy, the benefits of drug vectors can vary from patient to patient based on differences in tumor microenvironments. Although systemic pharmacokinetics (PK) of drugs is considered as the major determinant of its efficacy in clinics, recent clinical and basic research indicates that tumor-based PK can provide better representation of therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
